Bimekizumab 4-year Efficacy in High-impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s432. https://doi.org/10.25251/skin.8.supp.432